Eupraxia Pharmaceuticals ... (EPRX)
NASDAQ: EPRX
· Real-Time Price · USD
5.87
-0.04 (-0.68%)
At close: Oct 16, 2025, 3:59 PM
5.87
0.00%
After-hours: Oct 16, 2025, 04:10 PM EDT
-0.68% (1D)
| Bid | 5.3 |
| Market Cap | 210.95M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -28.96M |
| EPS (ttm) | -0.86 |
| PE Ratio (ttm) | -6.83 |
| Forward PE | -5.93 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 6.29 |
| Volume | 40,482 |
| Avg. Volume (20D) | 75,287 |
| Open | 5.93 |
| Previous Close | 5.91 |
| Day's Range | 5.71 - 5.93 |
| 52-Week Range | 2.31 - 7.19 |
| Beta | 1.49 |
| Ex-Dividend Date | n/a |
About EPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-14.89%
Eupraxia Pharmaceuticals shares are trading lower ...
Unlock content with
Pro Subscription
2 months ago
+1.49%
Eurpraxia Pharmaceuticals shares are trading higher following the release of its Q2 financial results.
